Hydroxychloroquine may have a treatment role for chronic inflammatory cardiomyopathy
1. Hydroxychloroquine plus prednisolone reduced the 12-month risk of the composite cardiovascular outcome by 72 percent compared with prednisolone alone. ...
Tag: hydroxychloroquine
Use of hydroxychloroquine may be protective for cardiovascular events in patients with systemic lupus erythematosus
1. In this observational cohort study of patients with systemic lupus erythematosus, the current use of hydroxychloroquine as a treatment ...
#VisualAbstract: Comparison between hydroxychloroquine and systemic corticosteroids in IgA nephropathy
1. For patients with IgA nephropathy (IgAN), long-term use of hydroxychloroquine demonstrated antiproteinuric effects compared to corticosteroids at 24 months. ...
Comparison between hydroxychloroquine and systemic corticosteroids in IgA nephropathy
1. For patients with IgA nephropathy (IgAN), long-term use of hydroxychloroquine demonstrated antiproteinuric effects compared to corticosteroids at 24 months. ...
Risk of hydroxychloroquine retinopathy increases with longer use and higher dosage
1. In this retrospective cohort study, the incidence of hydroxychloroquine retinopathy was 2.5% at 10 years, increasing to 8.6% at ...
Remdesivir does not reduce mortality in ventilated patients with COVID-19
1. No significant decrease in mortality risk was seen in ventilated patients with COVID-19 on remdesivir compared to control. 2. ...
Hydroxychloroquine and lopinavir-ritonavir not effective against SARS-CoV-2
1. Hydroxychloroquine and lopinavir-ritonavir did not significantly decrease COVID-19–associated hospitalization or improve other secondary clinical outcomes. Evidence Rating Level: 1 ...
#VisualAbstract: Hydroxychloroquine not effective for preventing COVID-19 after contact exposure
1. Postexposure hydroxychloroquine therapy did not prevent coronavirus disease 2019 (Covid-19) infection in exposed healthy individuals. 2. Hydroxychloroquine treatment after ...
Hydroxychloroquine may not prevent Covid-19 after contact exposure
1. Postexposure hydroxychloroquine therapy did not prevent coronavirus disease 2019 (Covid-19) infection in exposed healthy individuals. 2. Hydroxychloroquine treatment after ...
Adding azithromycin to hydroxychloroquine does not improve clinical outcomes in COVID-19 patients
1. The addition of azithromycin to standard of care, which included hydroxychloroquine, did not improve clinical outcomes compared to standard ...
